Richard Bernstein, MD
Pulmonary Disease · Annapolis, MDNPI 1013106178
Payments from drug & device makers
Across 1,604 payments — averaging $3546.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$5.3M
- Sanofi$143K
- GSK$109K
- Sanofi US Services Inc.$71K
- AstraZeneca$35K
- Novartis$18K
- plus $3K from 8 others
Across 9 payments — averaging $202.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$1K
- Janssen Scientific Affairs, LLC$500
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 1,500 | $5,308,112 |
| Sanofi | 42 | $143,369 |
| GSK | 33 | $108,990 |
| Sanofi US Services Inc. | 12 | $71,131 |
| AstraZeneca | 3 | $35,330 |
| Novartis | 3 | $18,146 |
| Chiesi USA, Inc. | 3 | $2,629 |
| Boehringer Ingelheim | 1 | $84 |
| Novo Nordisk | 2 | $40 |
| Lilly USA, LLC | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Resmed Corp | 1 | $17 |
| United Therapeutics Corporation | 1 | $17 |
| Dentsply Sirona Inc | 1 | $16 |
How this compares
$5,687,923 in reported general payments places this provider in the 95th percentile of 297 pulmonary disease providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Annapolis
- Alan SchwartzBaltimore$1.6M
- Sonye DanoffBaltimore$1.5M
- Michael DrummondBaltimore$1.4M
- da Wei LiaoBethesda$1.3M
- Paul HassounBaltimore$1.3M
- Lonny YarmusBaltimore$1.2M
- Jonathan SevranskyBaltimore$971K
- Robert ChasseSalisbury$788K
- Robert WiseBaltimore$761K
- Nancy LinBaltimore$758K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.